L30 - Anticoagulant therapy Flashcards
Mechanism of platelet plug formation?
1) Damaged endothelial cells (wall defect) expose collagen for GP Ib on resting platelets to stick to through von Willebrand’s factor (vWF)
2) Activated platelets degranulate (ADP, TXA2, 5-HT)»_space; bind to receptors on platelets»_space; express GP IIb/IIIa (= receptor for fibrinogen)»_space; form fibrin
Which coagulation pathway initiates immediate clotting?
Extrinsic pathway
TF/Factor 7a complex form within seconds
List 3 major physiological responses to blood vessel damage?
• Vasoconstriction • Platelet plug formation • Coagulation
Compare the activators of intrinsic and extrinsic pathways
Intrinsic = response to damage to endothelial cells or phospholipids released by activated platelets
Extrinsic = “tissue factor” leaks into the blood
2 major factors of thrombosis?
- Endothelial injury, e.g.:
Hypertension
Hyperlipidemia, diabetes mellitus (oxidative stress)
Infection (inflammation of endothelium) - Abnormal/turbulent blood flow, e.g.:
Atherosclerotic plaques
Cardiac arrhythmias
Name the 3 classes of anticoagulants and their function?
Antiplatelet agents*: inhibit Platelet adhesion, activation and aggregation
Anticoagulants*: inhibit activation of coagulation cascade
Thrombolytic agents: Breakdown formation of thrombus
- = prevention only
Name 4 antiplatlet agents?
- Cyclooxygenase (COX) inhibitor (aspirin)
- ADP receptor antagonists (clopidogrel, prasugrel)
- Glycoprotein (GP) IIb/IIIa receptor inhibitors
- Dipyridamole
Indication for low dose aspirin?
primary prevention of myocardial infarction (heart attack), ischemic stroke
Indication for Clopidogrel, prasugrel?
cannot tolerate aspirin (e.g. stomachache)
Indication for aspirin + clopidogrel?
(synergistic): e.g. after coronary angioplasty, stenting = prevent thrombosis
MoA of aspirin?
1) Forms covalent bond to irreversibly inhibit cyclooxygenase-1 (COX-1: cannot turn arachidonic acid (from membrane phospholipids) into prostaglandin H2)
2) Block thromboxane A2 (TXA2) synthesis in platelet
3) Decrease platelet aggregation
ADR of aspirin and clopidogrel?
Aspirin Increase incidence of gastric irritation, bleeding
= avoid in patients with peptic ulcer
Both increase Risk of prolonged bleeding
MoA of ADP receptor antagonists?
block P2Y receptors (= ADP receptor) = inhibit ADP-mediated platelet aggregation (cannot activate GPllb/IIIa receptors)
MoA of Glycoprotein (GP) IIb/IIIa receptor inhibitors? Give 3 examples?
1) Abciximab = monoclonal antibody to glycoprotein IIb/IIIa receptors
2) Eptifibitide, tirofiban = reversible blockers of glycoprotein IIb/IIIa receptors
Block GP IIb/IIIa receptors = prevent binding of fibrinogen to platelets = decrease platelet aggregation
Indication for GP IIb/IIIa receptor inhibitors?
given IV during coronary angioplasty, stenting
MoA of Dipyridamole? (2)
Increase cAMP in plt = prevent aggregation
- Inhibits phosphodiesterase»_space; cannot break down cAMP»_space; Increase intracellular cAMP levels in platelet
» decrease Ca2+
» inhibit platelet aggregation - Inhibits cellular reuptake of adenosine into platelets»_space; increase extracellular [adenosine]»_space; more can stimulate adenosine (A2) receptor
» more adenylate cyclase converts ATP to cAMP
» Decrease Ca2+
» inhibit platelet activation, aggregation
Preparation of Dipyridamole?
Ineffective when used alone
usually given in combination with aspirin / warfarin
Name 4 types of anticoagulants?
Heparin
Direct thrombin inhibitors
Direct factor Xa inhibitors
Warfarin